The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma

Pediatrics

Volumn 97, Issue 2, 1996, Pages 246-250

  Andrich, Mary P ^a   Shalaby Rana, Eglal ^a   Movassaghi, Nasser ^b   Majd, Massoud ^a,c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

correlative imaging; metaiodobenzylguanidine; neuroblastoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INFANT; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROBLASTOMA; NUCLEAR MEDICINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR DIAGNOSIS;

3-IODOBENZYLGUANIDINE; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; FEMALE; GANGLIONEUROBLASTOMA; GANGLIONEUROMA; HUMANS; INFANT; INFANT, NEWBORN; IODINE RADIOISOTOPES; IODOBENZENES; MALE; NEUROBLASTOMA; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030028814     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. 131I-mIBG and first attempts of its therapeutic use. Nuttearmedizin. 1984;(suppl 21):474-476
2. 131I]iodobenzylguanidine. Lancet. 1984;i:333-334
3. Englaro EE, Gelfand MJ, Harris RE, Smith HS. 1-131 MIBG imaging after bone marrow transplantation for neuroblastoma. Radiology. 1992;182: 515-520
4. Shulkin BL, Shapiro B, Hutchinson RJ. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma. J Nucl Med. 1992;33:1735-1740
5. Yeh SDJ, Larson SM, Burch L, et al. Radioimmunodetection of neuroblastoma with iodine-131-3F8. correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities. J Nucl Med. 1991;32:769-776
6. Gordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. Skeletal assessment in neuroblastoma - the pitfalls of iodine-123-MIBG scans. J Nucl Med. 1990;31:129-134
7. Jacobs A, DeIree M, Desprechins B, et al. Consolidating the role of * I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radiol 1990;20:157-159
8. Troncone L, Rufini V, Montemaggi P, Danza FM, Lasorella A, Mastrangelo R. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG): 5 years of experience. Eur J Nucl Med 1990;16:325-335
9. Garty I, Friedman A, Sandler MP, Kedar A. Neuroblastoma: imaging evaluation by sequential Tc-99m MDP, I-131 MIBG, and Ga-67 citrate studies. Clin Nucl Med. 1989,14:515-522
10. Schmiegelow K, Siiemes MA, Agertoft L, et al Radio-iodobenzylguanidine scintigraphy of neuroblastoma: conflicting results, when compared with standard investigations. Med Pediatr Oncol. 1989;17:126-130
11. Bouvier JF, Philip T, Chauvot P, et al Pitfalls and solutions in neuroblasloma diagnosis using radioiodine MIBG: our experience in about 50 cases. Adv Neuroblastoma Res. 1988;2:707-720
12. Heyman S, Evans AE, D'Angio GJ. I-131 metaiodobenzylguanidine: diagnostic use in neuroblastoma patients in relapse. Med Pediatr Oncol. 1988;16:337-340
13. Lumbroso JD, Guermazi F, Hartmann O, et al Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma. Sensitivity and specificity, a review of 115 scans Adv Neuroblastoma Res. 1988;2:689-705
14. 131I in neuroblastoma diagnosis and follow-up treatment with a review of the diagnostic results of the international workshop of pediatric oncology held in Rome, September 1986. Med Pediatr Oncol. 1987;15:181-187
15. Hoefnagel CA, Voute PA, de Kraker J, Marcuse HR. Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine. J Nucl Med 1987;28:308-314
16. 123I-meta-iodobcnzylguanidine (MIBG) scintigraphy. Ann Radiol (Paris). 1987;30:491-496
17. Hadley GP, Rabe E. Scanning with iodine-131 MIBG in children with solid tumors: an initial appraisal. J Nucl Med. 1986;27:620-626
18. 131I]benzylguanidine (MIBG) in the diagnosis and follow-up of neuroblastoma. Pediatr Hematol Oncol. 1986;3:37-47
19. 131 I-meta-iodobenzylguanidine in clinical diagnosis and staging of neuroectodermal tumors. Helv Paediatr Acta. 1986;41:63-67
20. 131I-Meta-iodobenzylguanidine scintigraphy of neuroblastomas. Semin Nucl Med. 1985;XV:154-160
21. Geatti O, Shapiro B, Sisson JC, et al. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases. J Nucl Med. 1985;26:736-742
22. Clerico A, Jenker A, Castello MA, Ciofetta G, Lucarelli C, Codini M. Functionally active ganglioneuroma with increased plasma and urinary catecholamines and positive iodine 131-meta-iodobenzylguanidine scintigraphy. Med Pediatr Oncal. 1991;19:329-333
23. Yoshizawa K, Fukumoto T, Hori T, Mima K, Morita J. Mediastinal ganglioneuroma with the secretive activity of catecholamines, visualized by 131-I-MIBG scintigraphy. Nippon Kyobu Geka Gakkai Zasshi. 1991;39:204-208
24. Hayes FA, Green AA, Rao BN. Clinical manifestations of ganglioneuroma. Cancer 1989;63:1211-1214
25. Tortajada JF, Carpena OC, Miralles AV, Menor CE, Sanchez VC. Visualizacion de un ganglioneuroma mediante gammagrafia con 1311-MIBG. Radiologia. 1987;29:286-288
26. Caballero O, Ferris J, Verdeguer A, Esquembre C, Castel V. Visualization of a ganglioneuroma by means of scintigraphy with 131-I-MIBG. Eur J Nucl Med. 1986;12:351-352
27. 123I-MIBG. Med Pediatr Oncol. 1987;15:170-177
28. Brodeur GM, Pritchard J, Berthold F, et al Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol, 1993;11:1466-1477
29. Lastoria S, Maurea S, Caraco C, et al. Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasound. Eur J Nucl Med 1993;20:1161-1167
30. Hutchinson RJ, Sisson JC, Shapiro B, et al. 131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma. Am J Clin Oncol. 1992;15:226-232
31. Lashford LS, Lewis IJ, Fielding SL, et al. Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation. J Clin Oncol. 1992;10:1889-1896